EE200100184A - Uudsed asendatud indolinoonid inhibeeriva toimegamitmesugustele kinaasidele ja tsükliin/CDK kompleksidele - Google Patents
Uudsed asendatud indolinoonid inhibeeriva toimegamitmesugustele kinaasidele ja tsükliin/CDK kompleksideleInfo
- Publication number
- EE200100184A EE200100184A EEP200100184A EEP200100184A EE200100184A EE 200100184 A EE200100184 A EE 200100184A EE P200100184 A EEP200100184 A EE P200100184A EE P200100184 A EEP200100184 A EE P200100184A EE 200100184 A EE200100184 A EE 200100184A
- Authority
- EE
- Estonia
- Prior art keywords
- cyclin
- kinases
- variety
- inhibitory activity
- novel substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19844003A DE19844003A1 (de) | 1998-09-25 | 1998-09-25 | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE19937496A DE19937496A1 (de) | 1999-08-07 | 1999-08-07 | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP1999/007040 WO2000018734A1 (de) | 1998-09-25 | 1999-09-22 | Neue substituierte indolinone mit inhibierender wirkung auf verschiedene kinasen und cyclin/cdk-komplexe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100184A true EE200100184A (et) | 2002-08-15 |
Family
ID=26049076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100184A EE200100184A (et) | 1998-09-25 | 1999-09-22 | Uudsed asendatud indolinoonid inhibeeriva toimegamitmesugustele kinaasidele ja tsükliin/CDK kompleksidele |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6855710B2 (zh) |
| EP (1) | EP1115704B1 (zh) |
| JP (1) | JP2002525356A (zh) |
| KR (1) | KR20010085841A (zh) |
| CN (1) | CN1319090A (zh) |
| AT (1) | ATE243195T1 (zh) |
| AU (1) | AU763361B2 (zh) |
| BG (1) | BG105327A (zh) |
| BR (1) | BR9914065A (zh) |
| CA (1) | CA2342622A1 (zh) |
| DE (1) | DE59906030D1 (zh) |
| DK (1) | DK1115704T3 (zh) |
| EA (1) | EA200100320A1 (zh) |
| EE (1) | EE200100184A (zh) |
| ES (1) | ES2196860T3 (zh) |
| HR (1) | HRP20010216A2 (zh) |
| HU (1) | HUP0104973A3 (zh) |
| ID (1) | ID27757A (zh) |
| IL (1) | IL141622A0 (zh) |
| NO (1) | NO20011477L (zh) |
| NZ (1) | NZ510845A (zh) |
| PL (1) | PL346898A1 (zh) |
| PT (1) | PT1115704E (zh) |
| SI (1) | SI1115704T1 (zh) |
| SK (1) | SK4032001A3 (zh) |
| TR (1) | TR200100854T2 (zh) |
| WO (1) | WO2000018734A1 (zh) |
| YU (1) | YU21301A (zh) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9904933D0 (en) | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
| US20030225152A1 (en) * | 2001-09-27 | 2003-12-04 | Andrews Steven W. | 3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
| US6797825B2 (en) | 2001-12-13 | 2004-09-28 | Abbott Laboratories | Protein kinase inhibitors |
| KR101022977B1 (ko) | 2002-03-26 | 2011-03-18 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | 글루코코르티코이드 모사체, 이의 제조방법, 약제학적조성물 및 이의 용도 |
| US7514468B2 (en) | 2002-07-23 | 2009-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions |
| PE20040701A1 (es) * | 2002-07-23 | 2004-11-30 | Boehringer Ingelheim Pharma | Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos |
| US7169936B2 (en) | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
| DE10233366A1 (de) * | 2002-07-23 | 2004-02-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE10237423A1 (de) | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
| US20040204458A1 (en) | 2002-08-16 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of Lck inhibitors for treatment of immunologic diseases |
| DE60333371D1 (de) * | 2002-08-29 | 2010-08-26 | Boehringer Ingelheim Pharma | 3-(sulfonamidoethyl)-indol-derivate zur verwendung als glucocorticoid-mimetika bei der behandlung von entzündlichen, allergischen und proliferativen erkrankungen |
| US7148249B2 (en) * | 2002-09-12 | 2006-12-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments |
| JP4879492B2 (ja) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | 疾患の治療のためのキナーゼ阻害剤 |
| US20050043233A1 (en) | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| UY28526A1 (es) | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
| JP4949845B2 (ja) * | 2003-10-03 | 2012-06-13 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | タンパク質キナーゼインヒビター結合アッセイにおける使用のための蛍光プローブ |
| WO2005094816A1 (en) | 2004-03-11 | 2005-10-13 | Actelion Pharmaceuticals Ltd | Indol-1-yl-acetic acid derivatives |
| US7795272B2 (en) | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| PE20061155A1 (es) * | 2004-12-24 | 2006-12-16 | Boehringer Ingelheim Int | Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas |
| US7741361B2 (en) | 2004-12-27 | 2010-06-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| MX2007012907A (es) * | 2005-04-28 | 2008-03-14 | Boehringer Ingelheim Int | Nuevos compuestos para el tratamiento de enfermedades inflamatorias. |
| JP2010512331A (ja) | 2006-12-06 | 2010-04-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グルココルチコイド模倣薬、それらの製造方法、医薬組成物、及びこれらの使用 |
| WO2008073509A2 (en) * | 2006-12-11 | 2008-06-19 | Genentech, Inc. | Compositions and methods for treating a neoplasm |
| CN101273991B (zh) * | 2007-03-28 | 2010-05-26 | 广东同德药业有限公司 | 四氢吲哚酮/四氢吲唑酮/四氢咔唑衍生物及其盐在制备抗病毒药物中的应用 |
| PE20091445A1 (es) | 2007-12-03 | 2009-10-19 | Boehringer Ingelheim Int | Derivados de indolinona y procedimiento para su fabricacion |
| RU2525114C2 (ru) * | 2007-12-03 | 2014-08-10 | Бёрингер Ингельхайм Интернациональ Гмбх | Способ получения производного индолинона |
| AU2009207862A1 (en) * | 2008-01-25 | 2009-07-30 | Boehringer Ingelheim International Gmbh | Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same |
| ATE541846T1 (de) | 2008-06-06 | 2012-02-15 | Boehringer Ingelheim Int | Glucocorticoidmimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und anwendungen davon |
| NZ590560A (en) | 2008-07-29 | 2012-12-21 | Boehringer Ingelheim Int | Indolinone Inhibitors of cell cycle kinases |
| WO2013137371A1 (ja) * | 2012-03-15 | 2013-09-19 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
| CN103664737A (zh) * | 2012-09-25 | 2014-03-26 | 杨子娇 | 一类治疗房角狭窄的化合物及其用途 |
| US11666888B2 (en) | 2018-02-05 | 2023-06-06 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
| CN114957084B (zh) * | 2022-01-21 | 2023-05-09 | 九江学院 | 一种吲哚酮类化合物及其制备方法和应用 |
| WO2025155711A1 (en) * | 2024-01-17 | 2025-07-24 | The Board Of Trustees Of The Leland Stanford Junior University | Lrrk2 inhibitors and compositions and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501567D0 (en) * | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
-
1999
- 1999-09-22 NZ NZ510845A patent/NZ510845A/en unknown
- 1999-09-22 ID IDW20010688A patent/ID27757A/id unknown
- 1999-09-22 HU HU0104973A patent/HUP0104973A3/hu unknown
- 1999-09-22 EE EEP200100184A patent/EE200100184A/xx unknown
- 1999-09-22 YU YU21301A patent/YU21301A/sh unknown
- 1999-09-22 PT PT99947404T patent/PT1115704E/pt unknown
- 1999-09-22 KR KR1020017003773A patent/KR20010085841A/ko not_active Withdrawn
- 1999-09-22 EA EA200100320A patent/EA200100320A1/ru unknown
- 1999-09-22 ES ES99947404T patent/ES2196860T3/es not_active Expired - Lifetime
- 1999-09-22 AT AT99947404T patent/ATE243195T1/de not_active IP Right Cessation
- 1999-09-22 IL IL14162299A patent/IL141622A0/xx unknown
- 1999-09-22 PL PL99346898A patent/PL346898A1/xx not_active Application Discontinuation
- 1999-09-22 AU AU60863/99A patent/AU763361B2/en not_active Ceased
- 1999-09-22 DE DE59906030T patent/DE59906030D1/de not_active Expired - Fee Related
- 1999-09-22 SI SI9930391T patent/SI1115704T1/xx unknown
- 1999-09-22 CA CA002342622A patent/CA2342622A1/en not_active Abandoned
- 1999-09-22 EP EP99947404A patent/EP1115704B1/de not_active Expired - Lifetime
- 1999-09-22 HR HR20010216A patent/HRP20010216A2/hr not_active Application Discontinuation
- 1999-09-22 WO PCT/EP1999/007040 patent/WO2000018734A1/de not_active Ceased
- 1999-09-22 BR BR9914065-9A patent/BR9914065A/pt unknown
- 1999-09-22 JP JP2000572194A patent/JP2002525356A/ja active Pending
- 1999-09-22 TR TR2001/00854T patent/TR200100854T2/xx unknown
- 1999-09-22 DK DK99947404T patent/DK1115704T3/da active
- 1999-09-22 SK SK403-2001A patent/SK4032001A3/sk unknown
- 1999-09-22 CN CN99811297A patent/CN1319090A/zh active Pending
-
2001
- 2001-03-09 BG BG105327A patent/BG105327A/xx unknown
- 2001-03-22 NO NO20011477A patent/NO20011477L/no not_active Application Discontinuation
-
2003
- 2003-09-19 US US10/666,643 patent/US6855710B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20040058978A1 (en) | 2004-03-25 |
| NZ510845A (en) | 2003-10-31 |
| HUP0104973A2 (hu) | 2002-04-29 |
| CN1319090A (zh) | 2001-10-24 |
| SK4032001A3 (en) | 2001-11-06 |
| ATE243195T1 (de) | 2003-07-15 |
| KR20010085841A (ko) | 2001-09-07 |
| EP1115704A1 (de) | 2001-07-18 |
| BG105327A (bg) | 2001-12-29 |
| SI1115704T1 (sl) | 2003-12-31 |
| CA2342622A1 (en) | 2000-04-06 |
| EP1115704B1 (de) | 2003-06-18 |
| NO20011477D0 (no) | 2001-03-22 |
| HUP0104973A3 (en) | 2002-06-28 |
| AU6086399A (en) | 2000-04-17 |
| HRP20010216A2 (en) | 2002-04-30 |
| PT1115704E (pt) | 2003-11-28 |
| PL346898A1 (en) | 2002-03-11 |
| DE59906030D1 (de) | 2003-07-24 |
| NO20011477L (no) | 2001-03-22 |
| AU763361B2 (en) | 2003-07-17 |
| WO2000018734A1 (de) | 2000-04-06 |
| ID27757A (id) | 2001-04-26 |
| ES2196860T3 (es) | 2003-12-16 |
| IL141622A0 (en) | 2002-03-10 |
| DK1115704T3 (da) | 2003-09-29 |
| TR200100854T2 (tr) | 2001-12-21 |
| JP2002525356A (ja) | 2002-08-13 |
| US6855710B2 (en) | 2005-02-15 |
| YU21301A (sh) | 2003-04-30 |
| BR9914065A (pt) | 2001-06-19 |
| EA200100320A1 (ru) | 2001-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200100184A (et) | Uudsed asendatud indolinoonid inhibeeriva toimegamitmesugustele kinaasidele ja tsükliin/CDK kompleksidele | |
| EE200000598A (et) | Kinaase ja tsükliin/CDK komplekse inhibeerivad asendatud indolinoonid | |
| EG24028A (en) | Aminothiazole inhibitors of cyclin dependent kinases | |
| NO20022864L (no) | Aminotiazol inhibitorer av syklin uavhengig kinase | |
| ATE306487T1 (de) | Purinhemmer von cyclinabhängiger kinase 2 und ikb-alpha | |
| FI964137A0 (fi) | Rotamaasi-entsyymiaktiivisuuden inhibiittoreita | |
| FI960089A7 (fi) | Proteiinikinaasi C:n oligonukleotidimodulaatio | |
| NO20001708D0 (no) | Fremgangsmåte for beskyttelse av overførte data | |
| FI965019A7 (fi) | Entsyymi-inhibiittoreita | |
| EE9800125A (et) | Rotamaasse ensümaatilise aktiivsuse inhibiitorid | |
| PT900210E (pt) | Derivados azahexano heterociclicos com actividade antviral | |
| EE9900600A (et) | Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena | |
| HUP0102527A3 (en) | Aryl phosphate derivatives of d4t having anti-hiv activity, medicaments containing the same and their use | |
| NO20003615D0 (no) | FremgangsmÕte for korreksjon av brønn-loggedata | |
| FR2776660B1 (fr) | Diazepino-indoles de phosphodiesterases iv | |
| BR9612373A (pt) | Derivados de tiol com atividade inibitória de metalopeptidase | |
| ZA200102260B (en) | Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes. | |
| DE69920224D1 (de) | Harnstoffderivate zur Schmerzbekämpfung | |
| BR9404204A (pt) | Massa cerâmica seca, refratária, e sua aplicação | |
| DE59813079D1 (de) | Fräszahn zur Erdbearbeitung | |
| DE50011817D1 (de) | Hydroxyethylstärke zur schmerzfreien und gewebeschonenden injektion von arzneimitteln | |
| NO20012276L (no) | Identifisering av SENV-genotyper | |
| NO992021D0 (no) | FramgangsmÕte for pulpbehandling av tremasse | |
| SI1071665T1 (sl) | Substituirani indolinoni, ki imajo inhibitorni učinek na kinaze in ciklin/CDK komplekse | |
| DE59608724D1 (de) | Medizinische Arbeitsmittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB1A | Correction of owner name or address | ||
| HC1A | Change of owner name |